Topical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis.
Huda MN, Borrego EA, Guerena CD, Varela-Ramirez A, Aguilera RJ, Hamadani CM, Tanner EEL, Badruddoza AZM, Agarwal SK, Nurunnabi M. Topical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis. ACS Pharmacol Transl Sci. 2023 May 12; 6(5):829-841.